Cannabis: Innovation Opportunities for its Medical Use

Author(s): Gerardo Angulo-Cuentas, José Ramírez-Vergara*, Maryuris Charris-Polo.

Journal Name: Recent Patents on Engineering

Volume 13 , Issue 3 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Cannabis is the most widely used illicit drug worldwide. Although cannabis can be considered a malignant drug that affects health and produces adverse effects on individuals, their families and society, it should be noted that therapeutic use has a scientific basis.

Objective: This study was carried out through a joint methodology that included both the analysis of patents and scientometrics, with the purpose of constructing a profile for the scientific, inventive and innovative activity of marijuana in medical uses.

Methodology: The analyses included indicators based on information about the publication and registration of scientific articles and patents, as well as impact indicators measured by the citations of the related publications, facilitating the establishment and understanding of the trends that were identified.

Results: As a result, it was intended to establish the state of the technologies, processes and research of this subject to determine whether it is in a state of growth maturity or decline. Additionally, ideas for novel studies are proposed, and information about countries, offices, authors and reference journals is shown to serve as a base for innovators, entrepreneurs and new researchers.

Conclusion: The main contribution of this article is the identification of companies and leading applicants in the medical use of cannabis, mainly in the formulation of medical preparations, treatments using these preparations, and heterocyclic compounds present in the Cannabis Sativa plant. Also, potential markets for the protection of inventions in the field are presented, and a review of outstanding articles and patents that can be used to know in depth the interests of the main applicants.

Keywords: Medical cannabis, profiling, patents, scientometrics, trends, malignant drug.

[1]
United Nations Office on Drugs and Crime, World drug report 2016., New York: United Nations , 2016.
[2]
M. Di Forti, C. Morgan, P. Dazzan, C. Pariante, V. Mondelli, and T. Marques, "Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study", The Lancet, vol. 2, pp. 233-238, 2015.
[3]
A. Zuardi, "Historia del cannabis como medicina: una revisión", Rev. Bras. Psiquiatr., vol. 28, pp. 153-157, 2006.
[4]
P.H. Gobira, L.R. Vilela, B.D. Gonçalves, R.P. Santos, A.C. de Oliveira, L.B. Vieira, and F.A. Moreira, "Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release", Neurotoxicology, vol. 50, pp. 116-121, 2015.
[5]
D. Piomelli, "The molecular logic of endocannabinoid signalling", Nat. Rev. Neurosciences., vol. 4, pp. 873-884, 2003.
[6]
A. Campos, F. Moreira, F. Gomes, and E. Del Bel,, "Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders", Philos. Trans. R. Soc. Lond. B: Biol. Sci., vol. 367, pp. 3364-3378,, 2012.
[7]
E.M. Mora-Valentín, M. Ortiz-de-Urbina-Criado, and J.J. Nájera- Sánchez, "Mapping the conceptual structure of science and technology parks", J. Technol. Transf., vol. 43, pp. 1410-1435, 2018.
[8]
G. Lourinho, P. Brito, and L. Rodrigues, "Hydrogen production via water electrolysis: patent search and analysis", Rec. Pat. Eng., vol. 10, pp. 196-207, 2016.
[9]
R. Tung, "Biphenyl-pyrazolecarboxamide compounds", U.S. Patent 2007033366, 2007.
[10]
F. Grotenhermen, "Pharmacokinetics and Pharmacodynamics of Cannabinoids", Clin. Pharmacokinet, vol. 42, pp. 327-360, 2003.
[11]
B. Whittle, G. Guy, and G. Geoffrey, "Mucoadhesive pharmaceutical formulations", UK Patent 200264109.. 2002
[12]
R.C, Altisen, J.F. Costansa, and B.G. Silva, "Substituted pyrazoline compounds, their preparation and use as medicaments", SP Patent 2005077911. 2005
[13]
C. Turner, M. ElSohly, and E. Boeren,, "Constituents of Cannabis sativa L. XVII. A review of the natural constituents", J. Nat. Prod., vol. 43, pp. 169-234,, 1980.
[14]
S. Ross, and M. ElSohly,, "Constituents of Cannabis Sativa L. XXVIII. A review of the natural constituents: 1980-1994", Zagazig J. Pharm. Sci., vol. 4, pp. 1-10, 1995.
[15]
M. ElSohly, and D. Slade, "Chemical constituents of marijuana: The complex mixture of natural cannabinoids", Life Sci., vol. 5, pp. 539-548, 2005.
[16]
T. Kim, and T. Cho, "Patent technologies in an artificial tree", Rec. Pat. Eng., vol. 11, pp. 125-133, 2017.
[17]
A. Baiano, A. Conte, F. Conto, and M.A. Del Nobile,, "“Recent patents in wine industry", Rec. Pat. Eng., vol. 7, pp. 25-40, 2013.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 3
Year: 2019
Page: [212 - 223]
Pages: 12
DOI: 10.2174/1872212112666181022155150
Price: $58

Article Metrics

PDF: 24
HTML: 3